1389 related articles for article (PubMed ID: 15820064)
21. Stimulatory and inhibitory differentiation of human myeloid dendritic cells.
Chakraborty A; Li L; Chakraborty NG; Mukherji B
Clin Immunol; 2000 Feb; 94(2):88-98. PubMed ID: 10637093
[TBL] [Abstract][Full Text] [Related]
22. Optimization of the concentration of autologous serum for generation of leukemic dendritic cells from acute myeloid leukemic cells for clinical immunotherapy.
Choi BH; Kang HK; Park JS; Kim SK; Pham TN; Zhu XW; Cho D; Nam JH; Chung IJ; Kim YJ; Rhee JH; Kim HJ; Lee JJ
J Clin Apher; 2006 Dec; 21(4):233-40. PubMed ID: 17120232
[TBL] [Abstract][Full Text] [Related]
23. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
[TBL] [Abstract][Full Text] [Related]
24. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
25. [Changes in the immune function of dendritic cells (DC) derived from HBV-related hepatocellular carcinoma (HCC) patient's peripheral blood monocytes (PBMC) pulsed with tumor antigen].
Wong YQ; Qiu SJ; Tang ZY; Ye SL; Liu YK; Fan J; Sun RX; Zhao Y
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):339-42. PubMed ID: 15918966
[TBL] [Abstract][Full Text] [Related]
26. The generation of leukemic dendritic cells from acute myeloid leukemia cells is potentiated by the addition of CD40L at the terminal maturation stage.
Lee JJ; Choi BH; Nam JH; Park MS; Song WH; Yang DH; Kim YK; Cho SH; Chung IJ; Park KS; Lee IK; Kim HJ
J Clin Apher; 2004; 19(3):130-6. PubMed ID: 15493054
[TBL] [Abstract][Full Text] [Related]
27. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
[TBL] [Abstract][Full Text] [Related]
28. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
29. Activation and differentiation of myelomonocytic cells in rheumatoid arthritis and healthy individuals--evidence for antagonistic in vitro regulation by interferon-gamma and tumor necrosis factor alpha, granulocyte monocyte colony stimulating factor and interleukin 1.
Seitz M; Zwicker M; Pichler W; Gerber N
J Rheumatol; 1992 Jul; 19(7):1038-44. PubMed ID: 1380987
[TBL] [Abstract][Full Text] [Related]
30. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
31. HBsAg loading on dendritic cells in patients with chronic hepatitis B: expressions of phenotypic molecules.
Tong HS; Zhang Y; Yuan K; Fu XW
Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):56-9. PubMed ID: 16481284
[TBL] [Abstract][Full Text] [Related]
32. [In vitro anti-tumor effect of CTL induced by HSP70-Id complex-modified dendritic cells].
Wang ZH; Ye Q; Hu ZQ; Ye ZQ; Yu X; Shen GX
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):481-5. PubMed ID: 17147108
[TBL] [Abstract][Full Text] [Related]
33. [The comparison of inducing specific CTL by two methods of leukemia cell antigen loading of DCs and fusion of DCs with leukemia cells].
Sheng LX; Qiu GQ; Xie XB; Gu WY; Wang ZL; Wu HQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar; 21(2):205-9. PubMed ID: 15766407
[TBL] [Abstract][Full Text] [Related]
34. In vitro inducing effect of dendritic cells cotransfected with survivin and granulocyte-macrophage colony-stimulating factor on cytotoxic T cell to kill leukemic cells.
Zhu XP; Chen ZZ; Li CT; Lin X; Zhuang JL; Hu JD; Yang T; Xu ZS
Chin Med J (Engl); 2008 Nov; 121(21):2180-4. PubMed ID: 19080181
[TBL] [Abstract][Full Text] [Related]
35. Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10.
Janelidze S; Enell K; Visse E; Darabi A; Salford LG; Siesjö P
Immunol Lett; 2005 Nov; 101(2):193-201. PubMed ID: 16002150
[TBL] [Abstract][Full Text] [Related]
36. IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells.
Menetrier-Caux C; Thomachot MC; Alberti L; Montmain G; Blay JY
Cancer Res; 2001 Apr; 61(7):3096-104. PubMed ID: 11306493
[TBL] [Abstract][Full Text] [Related]
37. Cytokines in the generation and maturation of dendritic cells: recent advances.
Zou GM; Tam YK
Eur Cytokine Netw; 2002; 13(2):186-99. PubMed ID: 12101074
[TBL] [Abstract][Full Text] [Related]
38. Interferon gamma impairs the ability of monocyte-derived dendritic cells to present tumour-specific and allo-specific antigens and reduces their expression of CD1A, CD80 AND CD4.
Rongcun Y; Maes H; Corsi M; Dellner F; Wen T; Kiessling R
Cytokine; 1998 Oct; 10(10):747-55. PubMed ID: 9811527
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of monocyte-derived dendritic cells under the influence of platelets.
Nguyen XD; Müller-Berghaus J; Kälsch T; Schadendorf D; Borggrefe M; Klüter H
Cytotherapy; 2008; 10(7):720-9. PubMed ID: 18985478
[TBL] [Abstract][Full Text] [Related]
40. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]